1Zeng Yi and Wu Zunyou(Institute of Virology, Chinese Academy of Preventive Medicine,National Center for AIDS Prevention and Control, Chinese Academy of Preventive Medicine).Control of Aids Epidemic in China[J].Bulletin of the Chinese Academy of Sciences,2000,14(2):106-111. 被引量：2
4[1]Poignard P, Saphire E O, Parren P W, et al. gp120: Biologic aspects of structural features[J]. Annu Rev Immunol, 2001, 19: 253-274.
5[2]Sambrook J, Fritsch E F, Maniatis T(translated by Jin dongyan, Li mengfeng et al). Molecular Cloning A Labortory Manual. 2nd ed[M]. BeiJing, Science Book Concern, 1992: 16-68.
6[3]Wang B, Ugen E K, V Strikantan, et al. Gene inoculation generates immune responses against human immunodeficiency virus type 1[J]. Proc Natl Acad Sci USA, 1993, 90(9): 4156-4160.
7[4]MacGregor R R, Boyer J D, Ugen K E, et al. First human trial of a DNA-Based vaccine for treatment of human immunodeficiency virus type 1 infection: safety and host response[J]. J Infect Dis, 1998, 178(1): 92-100.
8[5]Richmond J F, Lu S, Santoro J C, et al. Studies of the neutralizing activity and avidity of anti-human immunodeficiency virus type 1 Env antibody elicited by DNA priming and protein boosting[J]. J Virol, 1998, 72(11): 9092-9100.
9Barre Sinoussi F, Chermann J C, Rey E et al. Isolation of a T-lymphotropic retrovirus from a patient at risk for acquired immunodeficiency syndrome(AIDS)[J]. Science, 1983, 220:868-871.
10Richman D D. HIV drug resistance [J]. AIDS Res Hum Retro. 1992,8: 1065-1071.
